Search results
Mar 1, 2024 · A third dose of either updated (2023–2024 Formula) Moderna vaccine or updated (2023–2024 Formula) Pfizer-BioNTech vaccine should be administered as follows: Ages 6 months–4 years: at least 8 weeks after the second dose
- FAQs for The Interim Clinical Considerations
A third dose of either updated (2023–2024 Formula) mRNA...
- Appendices, References, and Previous Updates
The previously authorized 3-dose Pfizer-BioNTech primary...
- Interim Clinical Considerations for Use of Covid-19 Vaccines
All people ages 65 years and older should receive 1...
- Vaccine Recipient Education
Many people have questions about the coronavirus disease...
- Recommendations
Interim Recommendations of the Advisory Committee on...
- ACIP General Best Practice Guidelines for Immunization
Vaccine scheduling, supply and lapsed schedule, spacing of...
- FAQs for The Interim Clinical Considerations
Mar 1, 2024 · Dose number: Originally 2, 21 days apart, with a third dose recommended for certain immunocompromised people and booster doses also available. But as of September 2023, primary vaccination...
Feb 29, 2024 · The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) approved the updated vaccines by Pfizer-BioNTech and Moderna for everyone 6 months and older, and authorized an updated Novavax vaccine for those 12 and older in the fall of 2023.
- 065208055
- kathy.katella-cofrancesco@yale.edu
Feb 29, 2024 · We administered mRNA-1273.214 or mRNA-1273 as a second booster in adults who had previously received a two-dose (100-μg) primary series and first booster (50-μg) dose of mRNA-1273 (≥3 months...
Feb 29, 2024 · On September 1, 2022, the Moderna and Pfizer–BioNTech bivalent vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) containing equal amounts of spike messenger RNA from...
Mar 19, 2024 · Watch on. Joshua Kline, MD, chief medical officer, PPG – Family Medicine, explains how a third dose or booster shot can help protect the population against COVID-19. An additional or third dose is particularly beneficial for those who have a compromised immune system.